WIN 54,461
Bromopravadoline[edit]
Bromopravadoline is a synthetic compound that acts as a cannabinoid receptor agonist. It is primarily used in scientific research to study the endocannabinoid system and its effects on pain management, inflammation, and other physiological processes.
Chemical Properties[edit]
Bromopravadoline is a derivative of pravadoline, a nonsteroidal anti-inflammatory drug (NSAID) that was initially developed for its analgesic properties. The addition of a bromine atom to the pravadoline structure enhances its affinity for cannabinoid receptors, particularly the CB1 receptor.
Mechanism of Action[edit]
Bromopravadoline exerts its effects by binding to and activating cannabinoid receptors in the central nervous system and peripheral nervous system. This activation leads to the modulation of neurotransmitter release, resulting in analgesic and anti-inflammatory effects. The compound's action on the CB1 receptor is similar to that of endogenous cannabinoids like anandamide and 2-arachidonoylglycerol.
Pharmacological Effects[edit]
The primary effects of bromopravadoline include:
- Analgesia: By activating cannabinoid receptors, bromopravadoline can reduce the perception of pain.
- Anti-inflammatory effects: It can decrease inflammation by modulating immune cell activity.
- Neuroprotection: Some studies suggest that bromopravadoline may have neuroprotective properties, potentially beneficial in conditions like neurodegenerative diseases.
Research Applications[edit]
Bromopravadoline is used in preclinical studies to explore the therapeutic potential of cannabinoid receptor agonists. It serves as a tool to understand the role of the endocannabinoid system in various physiological and pathological processes.
Safety and Toxicology[edit]
As with many research chemicals, the safety profile of bromopravadoline is not fully established. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian